DRIP score (drug-resistant pneumonia risk)
Risk of drug-resistant pathogens in community-acquired pneumonia.
Inputs
Antibiotic use within 60 days
Long-term care resident
Tube feeding
Infection with a drug-resistant pathogen within 1 year
Hospitalization within 60 days
Chronic pulmonary disease
Poor functional status
Gastric acid suppression
Wound care
MRSA colonization within 1 year
Worked calculation
Your values are highlighted.
- Points
When to use
- Adults hospitalized with pneumonia.
Pearls and pitfalls
- 4 or more: consider broad-spectrum coverage; below 4: standard CAP therapy is usually appropriate.
- IDSA/ATS 2019 favors local validation and prior MRSA or Pseudomonas isolation.
Why use
Outperforms the old HCAP definition.
| Criterion | Points |
|---|---|
| Antibiotic use within 60 days | +2 |
| Long-term care resident | +2 |
| Tube feeding | +2 |
| Infection with a drug-resistant pathogen within 1 year | +2 |
| Hospitalization within 60 days | +1 |
| Chronic pulmonary disease | +1 |
| Poor functional status | +1 |
| Gastric acid suppression | +1 |
| Wound care | +1 |
| MRSA colonization within 1 year | +1 |